Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea

Journal of the Autonomic Nervous System

Volumn 78, Issue 1, 1999, Pages 57-63

  Morrow, Gary R ^a   Hickok, Jane T ^a   Dubeshter, Brent ^b   Lipshultz, Steven E ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cancer; Chemotherapy; Nausea

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; NAUSEA; NERVE CONDUCTION; NERVE POTENTIAL; OVARY CANCER; PRIORITY JOURNAL; VOMITING;

AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARBOPLATIN; CISPLATIN; COLD; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; METOCLOPRAMIDE; MIDDLE AGED; NAUSEA; ONDANSETRON; OVARIAN NEOPLASMS; POSTURE; VALSALVA MANEUVER;

EID: 0033386201     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(99)00053-3     Document Type: Article

References (48)

1. Andrykowski M.A., Redd W.H., Hatfield A.K. Development of anticipatory nausea: a prospective analysis. J. Consult. Clin. Psychol. 53(4):1985;447-454.
2. Bennett, T., Gardiner, S.M., 1992. A commentary on clinical tests of autonomic function with particular reference to recent developments. In: Bannister, S.R.M. (Ed.), Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford Medical Publications, New York, pp. 391-412.
3. Bianchi, A.L., Grelot, L., 1992. An historical overview of emesis. In: Bianchi, A.L., Grelot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis. John Libby Eurotext, Montrouge, France, pp. 3-10.
4. Bonadonna G., Valagussa P. Dose-responsive effect adjuvant chemotherapy in breast cancer. N. Engl. J. Med. 304:1981;10-46.
5. Brizzee, K.R., Mehler, W.R., 1986. The central nervous connections involved in the vomiting reflex. In: Davis, C.J., Lake-Bakaar, G.V., Grahame-Smith, D.G. (Eds.), Nausea and Vomiting: Mechanisms and Treatments. Springer-Verlag, Berlin, pp. 31-55.
6. Bruera E., Catz Z., Hooper R., Lentle B., MacDonald N. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J. Pain Symp. Manage. 2:1987;19-21.
7. Campora, E., Giudici, S., Merlini, L., Rosso, R., 1992. Control of acute, delayed fec/fac-induced emesis and gi toxicity at subsequent cycles: a randomized trial of metoclopramide (mcp), dexamethasone (dx) and orphenadrine vs. ondansetron (ond) and dx (meeting abstract). Proc. Annu. Meet. Am. Soc. Clin. Oncol. 11, 390.
8. Carey M.P., Burish T.G. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol. Bull. 104(3):1988;307-325.
9. Carr B.I., Bertrand M., Browning S., Doroshow J.H., Presant C., Pulone B., Hill L.R. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study. J. Clin. Oncol. 3(8):1985;1127-1132.
10. Cowings P.S., Suter S., Toscano W.B., Kamiya J., Naifeh K. General autonomic components of motion sickness. Psychophysiology. 23:1986;542-551.
11. du Bois A., Meerpohl H.G., Christman N.D.et al. Antiemetic therapy with a 5HT3-antagonist ondansetron in cisplatin induced vomiting refractory to standard antiemetic regimens. Proc. ASCO. 10:1991;348.
12. Dunkin, G., Johnson, R.H., Lambie, D.G., Whiteside, E.A., 1980. Evidence of vagal neuropathy in chronic alcoholics. Lancet, 1053-1057.
13. Dunlap, W.H., Pfeifer, M.A., 1989. Autonomic function testing. In Schneiderman, N., Weiss, S.M., Kaufmann, P.G. (Eds.), Handbook of Research Methods in Cardiovascular Behavioral Medicine. Plenum, New York, pp. 91-106.
14. Edmonds, M.E., Jones, T.C., Saunders, W.A., Sturrock, R.D., 1979. Autonomic neuropathy in rheumatoid arthritis. BMJ, 173-175.
15. Ewing, D.J., 1983. Practical bedside investigation of diabetic autonomic failure. In: Bannister, R. (Ed.), Autonomic Failure. Oxford Univ. Press, Oxford, England, pp. 371-405.
16. Ewing D.J., Campbell I.W., Murray A.et al. Immediate heart rate response to standing. BMJ. 1:1978;145-147.
17. Ewing D.J., Martyn C.N., Young R.J., Clarke B.F. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 8:1985;491-498.
18. Gard D., Harris J., Edwards P.W., McCormack G. Sensitizing effects of pretreatment measures on cancer chemotherapy nausea and vomiting. J. Consult. Clin. Psychol. 56:1988;80-84.
19. Gautschy B., Weidmann P., Gnadinger M.P. Autonomic function tests as related to age and gender in normal man. Klin. Wochenschr. 64(11):1986;499-505.
20. Gelber D.A., Pfeifer M., Dawson B., Schumer M. Cardiovascular autonomic nervous system tests: determination of normative values and effect of confounding variables. J. Auton. Nerv. Syst. 62(1-2):1997;40-44.
21. Genovely H., Pfeifer M.A. RR-variation: the autonomic test of choice in diabetes. Diabetes/Metab. Rev. 4:1988;255-271.
22. Harris J.G. Nausea, vomiting and cancer treatment. Ca: A Cancer Journal for Clinicians. 28(4):1978;194-201.
23. Hynes E.A., Brown E.G.E. The cold pressor test for measuring the reactability of the blood pressure. Am. Heart J. 11:1936;1-9.
24. Levin A.B. A simple list of cardiac function based upon the heart rate changes induced by the valsalva maneuver. Am. J. Cardiol. 18:1966;909-919.
25. Low P.A. Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. Mayo Clin. Proc. 68(8):1993;748-752.
26. Mackay J.D., Page M., McCambridge J., Watkins P.J. Diabetic autonomic neuropathy the diagnostic value of heart rate monitoring. Diabetologia. 18:1980;471-478.
27. Malpas S.C., Whiteside E.A., Maling T.J.B. Heart rate variability and cardiac autonomic function in men with chronic alcohol dependence. Brit. Heart J. 65:1991;84-88.
28. Mathias, C.J., Bannister, R., 1992. Investigation of autonomic disorders. In Bannister, S.R.M. (Ed.), Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford Medical Publications, New York, pp. 255-290.
29. McLeod D.R., Hoehn-Saric R., Stefan R.L. Somatic symptoms of anxiety: comparison of self-report and physiological measures. Biol. Psychiatry. 21:1986;301-310.
30. Miller, S.M., 1981. Predictability and stress: Towards a clarification of evidence and theory. In: Anonymous, Advances in Experimental Social Psychology. Academic Press, New York, pp. 203-256.
31. Morrow G.R. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer. 55(12):1985;2766-2770.
32. Morrow G.R. Chemotherapy-related nausea and vomiting: etiology and management. Ca: A Cancer Journal for Clinicians. 39(2):1989;89-104.
33. Morrow, G.R., 1992. Behavioural factors influencing the development and expression of chemotherapy induced side effects. [Review]. Brit. J. Cancer - Suppl., 19, S54-S60; discussion S60-S63.
34. Morrow G.R., Lindke J., Black P.M. Anticipatory nausea development in cancer patients: replication and extension of a learning model. Br. J. Psychol. 82(Pt 1):1991;61-72.
35. Morrow G.R., Hickok J.T., Burish T.G. Behavioral aspects of clinical trials. An integrated framework from behavior theory [Review]. Cancer. 74(9):1994;2676-2682. Suppl.
36. Morrow G.R., Hickok J.T., Rosenthal S.N. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer. 76:1995;343-357.
37. Morrow G.R., Roscoe J.A., Hynes H.E., Flynn P.J., Pierce H.I., Burish T. Progress in reducing anticipatory nausea and vomiting: a study of community practice. Supportive Care in Cancer. 6(1):1998;46-50.
38. Naik R.B., Mathias C.J., Wilson C.A., Reed J.L., Warren D.J. Cardiovascular and autonomic reflexes in haemodialysis. Clin. Sci. 60:1981;165-170.
39. Nerenz D.R., Leventhal H., Love R.R. Factors contributing to emotional distress during cancer chemotherapy. Cancer. 50(5):1982;1020-1027.
40. The Quality of life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group, Osoba D., Zee B., Warr D., Latreille J., Kaizer L., Pater J. Effect of postchemotherapy nausea and vomiting on health-related quality of life. Supportive Care in Cancer. 5:1997;307-313.
41. Redd W.H. Behavioral approaches to treatment-related distress [Review]. Ca: a Cancer Journal for Clinicians. 38(3):1988;138-145.
42. Richardson G.L., Sheldon D.R., Krailom The effect of compliance with treatment on survival among patients with hematologic malignancies. J. Clin. Oncol. 8:1990;356-364.
43. Schneiderman, N., McCabe, P.M., 1989. Psychophysiologic strategies in laboratory research. In: Schneiderman, S.M.W. (Ed.), Handbook of Research Methods in Cardiovascular Behavioral Medicine. Plenum, New York, pp. 349-364.
44. Stern, R.M., Koch, K.L., 1985. Electrogastrography: Methodology, Validation and Applications. Praeger, New York.
45. Sundkist C., Almer L.O., Lija B. Respiratory influence of the heart rate in diabetes mellitus. BMJ. 1:1979;924-925.
46. Thomson P.D., Melmon K.L. Clinical assessment of autonomic function. Anesthesiology. 29(4):1968;724-731.
47. Whitehead, S.A., Holden, W.A., Andrews, P.L.R., 1992. Pregnancy sickness. In: Bianchi, A.L., Grelot, L., Miller, A.D., King, G.L. (Eds.), Mechanisms and Control of Emesis. John Libby Eurotext, Montrouge, France, pp. 297-306.
48. Wieling, W., 1993. Non-invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In: Bannister, S.R., Mathias, C.J. (Eds.), Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford Univ. Press, New York, pp. 291-311.